BACKGROUND. Nitric oxide has been identified as an endothelium-derived relaxing factor in blood vessels. We tried to determine whether it is involved in the relaxation of the corpus cavernosum that allows penile erection. The relaxation of this smooth muscle is known to occur in response to stimulation by nonadrenergic, noncholinergic neurons. METHODS. We studied strips of corpus cavernosum tissue obtained from 21 men in whom penile prostheses were inserted because of impotence. The mounted smooth-muscle specimens were pretreated with guanethidine and atropine and submaximally contracted with phenylephrine. We then studied the smooth-muscle relaxant responses to stimulation by an electrical field and to nitric oxide. RESULTS. Electrical-field stimulation caused a marked, transient, frequency-dependent relaxation of the corpus cavernosum that was inhibited in the presence of N-nitro-L-arginine and N-amino-L-arginine, which selectively inhibit the biosynthesis of nitric oxide from L-arginine. The addition of excess L-arginine, but not D-arginine, largely reversed these inhibitory effects. The specific liberation of nitric oxide (by S-nitroso-N-acetylpenicillamine) caused rapid, complete, and concentration-dependent relaxation of the corpus cavernosum. The relaxation caused by either electrical stimulation or nitric oxide was enhanced by a selective inhibitor of cyclic guanosine monophosphate (GMP) phosphodiesterase (M&B 22,948). Relaxation was inhibited by methylene blue, which inhibits cyclic GMP synthesis. CONCLUSIONS. Our findings support the hypothesis that nitric oxide is involved in the nonadrenergic, noncholinergic neurotransmission that leads to the smooth-muscle relaxation in the corpus cavernosum that permits penile erection. Defects in this pathway may cause some forms of impotence.
Source Information
Department of Surgery, University of California School of Medicine, Los Angeles.
This article has been cited by other articles:
Cheng, J. W. M., Berhane, S. R.
(2009). Managing Erectile Dysfunction in Patients With Cardiovascular Diseases: The Efficacy and Safety of Phosphodiesterase-5 Inhibitors. AMERICAN JOURNAL OF LIFESTYLE MEDICINE
3: 201-211
[Abstract]
d'Emmanuele di Villa Bianca, R., Sorrentino, R., Maffia, P., Mirone, V., Imbimbo, C., Fusco, F., De Palma, R., Ignarro, L. J., Cirino, G.
(2009). Hydrogen sulfide as a mediator of human corpus cavernosum smooth-muscle relaxation. Proc. Natl. Acad. Sci. USA
106: 4513-4518
[Abstract][Full Text]
Soukhova-O'Hare, G. K., Shah, Z. A., Lei, Z., Nozdrachev, A. D., Rao, C. V., Gozal, D.
(2008). Erectile Dysfunction in a Murine Model of Sleep Apnea. Am. J. Respir. Crit. Care Med.
178: 644-650
[Abstract][Full Text]
Kass, D. A., Champion, H. C., Beavo, J. A.
(2007). Phosphodiesterase Type 5: Expanding Roles in Cardiovascular Regulation. Circ. Res.
101: 1084-1095
[Abstract][Full Text]
Imamura, M., Waseda, Y., Marinova, G. V., Ishibashi, T., Obayashi, S., Sasaki, A., Nagai, A., Azuma, H.
(2007). Alterations of NOS, arginase, and DDAH protein expression in rabbit cavernous tissue after administration of cigarette smoke extract. Am. J. Physiol. Regul. Integr. Comp. Physiol.
293: R2081-R2089
[Abstract][Full Text]
Raina, R., Pahlajani, G., Agarwal, A., Zippe, C. D.
(2007). Treatment of Erectile Dysfunction: Update. Am J Mens Health
1: 126-138
[Abstract]
Bivalacqua, T. J., Burnett, A. L., Hellstrom, W. J. G., Champion, H. C.
(2007). Overexpression of arginase in the aged mouse penis impairs erectile function and decreases eNOS activity: influence of in vivo gene therapy of anti-arginase. Am. J. Physiol. Heart Circ. Physiol.
292: H1340-H1351
[Abstract][Full Text]
Bivalacqua, T. J., Deng, W., Kendirci, M., Usta, M. F., Robinson, C., Taylor, B. K., Murthy, S. N., Champion, H. C., Hellstrom, W. J. G., Kadowitz, P. J.
(2007). Mesenchymal stem cells alone or ex vivo gene modified with endothelial nitric oxide synthase reverse age-associated erectile dysfunction. Am. J. Physiol. Heart Circ. Physiol.
292: H1278-H1290
[Abstract][Full Text]
Ohta, F., Takagi, T., Sato, H., Ignarro, L. J.
(2007). Low-dose L-arginine administration increases microperfusion of hindlimb muscle without affecting blood pressure in rats. Proc. Natl. Acad. Sci. USA
104: 1407-1411
[Abstract][Full Text]
Pacher, P., Beckman, J. S., Liaudet, L.
(2007). Nitric Oxide and Peroxynitrite in Health and Disease. Physiol. Rev.
87: 315-424
[Abstract][Full Text]
Tiefer, L.
(2006). The Viagra Phenomenon. Sexualities
9: 273-294
[Abstract]
Agarwal, A., Nandipati, K. C., Sharma, R. K., Zippe, C. D., Raina, R.
(2006). Role of Oxidative Stress in the Pathophysiological Mechanism of Erectile Dysfunction. J Androl
27: 335-347
[Full Text]
Beckman, T. J., Abu-Lebdeh, H. S., Mynderse, L. A.
(2006). Evaluation and Medical Management of Erectile Dysfunction. Mayo Clin Proc.
81: 385-390
[Abstract][Full Text]
Gocmen, C., Buyuknacar, H. S., Kots, A. Y., Murad, F., Kiroglu, O., Kumcu, E. K.
(2006). The Relaxant Activity of 4,7-Dimethyl-1,2,5-oxadiazolo[3,4-d]-pyridazine 1,5,6-Trioxide in the Mouse Corpus Cavernosum. J. Pharmacol. Exp. Ther.
316: 753-761
[Abstract][Full Text]
Copel, L., Katz, R., Blachar, A., Sosna, J., Sheiman, R. G.
(2005). Clinical and Duplex US Assessment of Effects of Sildenafil on Cavernosal Arteries of the Penis: Comparison with Intracavernosal Injection of Vasoactive Agents--Initial Experience. Radiology
237: 986-991
[Abstract][Full Text]
Fries, R., Shariat, K., von Wilmowsky, H., Bohm, M.
(2005). Sildenafil in the Treatment of Raynaud's Phenomenon Resistant to Vasodilatory Therapy. Circulation
112: 2980-2985
[Abstract][Full Text]
Young, J. M., Feldman, R. A., Auerbach, S. M., Kaufman, J. M., Garcia, C. S., Shen, W., Murphy, A. M., Beasley, C. M. Jr., Hague, J. A., Ahuja, S.
(2005). Tadalafil Improved Erectile Function at Twenty-Four and Thirty-Six Hours After Dosing in Men With Erectile Dysfunction: US Trial. J Androl
26: 310-318
[Abstract][Full Text]
Williams, B. A., Liu, C., DeYoung, L., Brock, G. B., Sims, S. M.
(2005). Regulation of intracellular Ca2+ release in corpus cavernosum smooth muscle: synergism between nitric oxide and cGMP. Am. J. Physiol. Cell Physiol.
288: C650-C658
[Abstract][Full Text]
Brown, J. S., Wessells, H., Chancellor, M. B., Howards, S. S., Stamm, W. E., Stapleton, A. E., Steers, W. D., Van Den Eeden, S. K., McVary, K. T.
(2005). Urologic Complications of Diabetes. Diabetes Care
28: 177-185
[Full Text]
Penson, D. F., Wessells, H.
(2004). Erectile Dysfunction in Diabetic Patients. Diabetes Spectr.
17: 225-230
[Abstract][Full Text]
Kim, N. N., Christianson, D. W., Traish, A. M.
(2004). Role of Arginase in the Male and Female Sexual Arousal Response. J. Nutr.
134: 2873S-2879S
[Abstract][Full Text]
Rosas-Vargas, H., Coral-Vazquez, R. M., Tapia, R., Borja, J. L., Salas, R. A., Salamanca, F.
(2004). Glu298Asp Endothelial Nitric Oxide Synthase Polymorphism Is a Risk Factor for Erectile Dysfunction in the Mexican Mestizo Population. J Androl
25: 728-732
[Abstract][Full Text]
Morgentaler, A.
(2004). A 66-Year-Old Man With Sexual Dysfunction. JAMA
291: 2994-3003
[Full Text]
Bivalacqua, T. J., Champion, H. C., Usta, M. F., Cellek, S., Chitaley, K., Webb, R. C., Lewis, R. L., Mills, T. M., Hellstrom, W. J. G., Kadowitz, P. J.
(2004). RhoA/Rho-kinase suppresses endothelial nitric oxide synthase in the penis: A mechanism for diabetes-associated erectile dysfunction. Proc. Natl. Acad. Sci. USA
101: 9121-9126
[Abstract][Full Text]
Balercia, G., Moretti, S., Vignini, A., Magagnini, M., Mantero, F., Boscaro, M., Ricciardo-Lamonica, G., Mazzanti, L.
(2004). Role of Nitric Oxide Concentrations on Human Sperm Motility. J Androl
25: 245-249
[Abstract][Full Text]
Fischer, M. E., Vitek, M. E., Hedeker, D., Henderson, W. G., Jacobsen, S. J., Goldberg, J.
(2004). A Twin Study of Erectile Dysfunction. Arch Intern Med
164: 165-168
[Abstract][Full Text]
Bivalacqua, T. J., Usta, M. F., Champion, H. C., Kadowitz, P. J., Hellstrom, W. J. G.
(2003). Endothelial Dysfunction in Erectile Dysfunction: Role of the Endothelium in Erectile Physiology and Disease. J Androl
24: S17-S37
[Full Text]
Guay, A. T.
(2003). Optimizing Response To Phosphodiesterase Therapy: Impact of Risk-Factor Management. J Androl
24: S59-S62
[Full Text]
Liu, P. Y., Death, A. K., Handelsman, D. J.
(2003). Androgens and Cardiovascular Disease. Endocr. Rev.
24: 313-340
[Abstract][Full Text]
Toda, N., Okamura, T.
(2003). The Pharmacology of Nitric Oxide in the Peripheral Nervous System of Blood Vessels. Pharmacol. Rev.
55: 271-324
[Abstract][Full Text]
Bredt, D. S.
(2003). Nitric Oxide Signaling in Brain: Potentiating the Gain with YC-1. Mol. Pharmacol.
63: 1206-1208
[Full Text]
Cirino, G., Sorrentino, R., di Villa Bianca, R. d'E., Popolo, A., Palmieri, A., Imbimbo, C., Fusco, F., Longo, N., Tajana, G., Ignarro, L. J., Mirone, V.
(2003). Involvement of beta 3-adrenergic receptor activation via cyclic GMP- but not NO-dependent mechanisms in human corpus cavernosum function. Proc. Natl. Acad. Sci. USA
100: 5531-5536
[Abstract][Full Text]
Bivalacqua, T. J., Armstrong, J. S., Biggerstaff, J., Abdel-Mageed, A. B., Kadowitz, P. J., Hellstrom, W. J. G., Champion, H. C.
(2003). Gene transfer of extracellular SOD to the penis reduces O2−{middle dot} and improves erectile function in aged rats. Am. J. Physiol. Heart Circ. Physiol.
284: H1408-H1421
[Abstract][Full Text]
Giuliano, F.
(2002). Phosphodiesterase type 5 inhibition in erectile dysfunction: an overview. Eur Heart J Suppl
4: H7-H12
[Abstract]
Jackson, G.
(2002). Phosphodiesterase type 5 inhibition in cardiovascular disease: experimental models and potential clinical applications. Eur Heart J Suppl
4: H19-H23
[Abstract]
Giuliano, F., Varanese, L.
(2002). Tadalafil: a novel treatment for erectile dysfunction. Eur Heart J Suppl
4: H24-H31
[Abstract]
Seftel, A. D.
(2002). Challenges in Oral Therapy for Erectile Dysfunction. J Androl
23: 729-736
[Full Text]
Schalcher, C., Schad, K., Brunner-La Rocca, H. P., Schindler, R., Oechslin, E., Scharf, C., Suetsch, G., Bertel, O., Kiowski, W.
(2002). Interaction of Sildenafil With cAMP-Mediated Vasodilation In Vivo. Hypertension
40: 763-767
[Abstract][Full Text]
Hellstrom, W. J. G.
(2002). The Molecular Basis of Erectile Physiology: From Bench to Bedside. J Androl
23: S3-S4
[Full Text]
Burnett, A. L.
(2002). Nitric Oxide Regulation of Penile Erection: Biology and Therapeutic Implications. J Androl
23: S20-S26
[Full Text]
Maas, R., Schwedhelm, E., Albsmeier, J., Boger, R. H
(2002). The pathophysiology of erectile dysfunction related to endothelial dysfunction and mediators of vascular function. Vasc Med
7: 213-225
[Abstract]
Gewaltig, M. T, Kojda, G.
(2002). Vasoprotection by nitric oxide: mechanisms and therapeutic potential. Cardiovasc Res
55: 250-260
[Abstract][Full Text]
Rochira, V., Granata, A. R. M., Balestrieri, A., Madeo, B., Carani, C.
(2002). Effects of Sildenafil on Nocturnal Penile Tumescence and Rigidity in Normal Men: Randomized, Placebo-Controlled, Crossover Study. J Androl
23: 566-571
[Abstract][Full Text]
Ignarro, L. J., Napoli, C., Loscalzo, J.
(2002). Nitric Oxide Donors and Cardiovascular Agents Modulating the Bioactivity of Nitric Oxide: An Overview. Circ. Res.
90: 21-28
[Abstract][Full Text]
Bivalacqua, T. J., Champion, H. C., Abdel-Mageed, A. B., Kadowitz, P. J., Hellstrom, W. J.G.
(2001). Gene Transfer of Prepro-Calcitonin Gene-Related Peptide Restores Erectile Function in the Aged Rat. Biol. Reprod.
65: 1371-1377
[Abstract][Full Text]
Baranano, D. E., Snyder, S. H.
(2001). Neural roles for heme oxygenase: Contrasts to nitric oxide synthase. Proc. Natl. Acad. Sci. USA
98: 10996-11002
[Abstract][Full Text]
Lepori, M., Sartori, C., Duplain, H., Nicod, P., Scherrer, U.
(2001). Interaction between cholinergic and nitrergic vasodilation: a novel mechanism of blood pressure control. Cardiovasc Res
51: 767-772
[Abstract][Full Text]
Kandeel, F. R., Koussa, V. K. T., Swerdloff, R. S.
(2001). Male Sexual Function and Its Disorders: Physiology, Pathophysiology, Clinical Investigation, and Treatment. Endocr. Rev.
22: 342-388
[Abstract][Full Text]
Cohan, P., Korenman, S. G.
(2001). Erectile Dysfunction. J. Clin. Endocrinol. Metab.
86: 2391-2394
[Full Text]
Angulo, J., Cuevas, P., Moncada, I., Martín-Morales, A., Allona, A., Fernández, A., Gabancho, S., Ney, P., de Tejada, I. S.
(2000). Rationale for the Combination of PGE1 and S-Nitroso-glutathione to Induce Relaxation of Human Penile Smooth Muscle. J. Pharmacol. Exp. Ther.
295: 586-593
[Abstract][Full Text]
Noto, T., Inoue, H., Ikeo, T., Kikkawa, K.
(2000). Potentiation of Penile Tumescence by T-1032, a New Potent and Specific Phosphodiesterase Type V Inhibitor, in Dogs. J. Pharmacol. Exp. Ther.
294: 870-875
[Abstract][Full Text]
Mohamed, E. A., MacDowall, P., Coward, R. A.
(2000). Timing of sildenafil therapy in dialysis patients--lessons following an episode of hypotension. Nephrol Dial Transplant
15: 926-927
[Full Text]
Ganz, M. B., Seftel, A.
(2000). Glucose-induced changes in protein kinase C and nitric oxide are prevented by vitamin E. Am. J. Physiol. Endocrinol. Metab.
278: E146-E152
[Abstract][Full Text]
Champion, H. C., Bivalacqua, T. J., Hyman, A. L., Ignarro, L. J., Hellstrom, W. J. G., Kadowitz, P. J.
(1999). Gene transfer of endothelial nitric oxide synthase to the penis augments erectile responses in the aged rat. Proc. Natl. Acad. Sci. USA
96: 11648-11652
[Abstract][Full Text]
Zanzinger, J.
(1999). Role of nitric oxide in the neural control of cardiovascular function. Cardiovasc Res
43: 639-649
[Abstract][Full Text]
Sullivan, M. E., Thompson, C. S., Dashwood, M. R., Khan, M. A., Jeremy, J. Y., Morgan, R. J., Mikhailidis, D. P.
(1999). Nitric oxide and penile erection: Is erectile dysfunction another manifestation of vascular disease?. Cardiovasc Res
43: 658-665
[Abstract][Full Text]
Escrig, A, Gonzalez-Mora, J L, Mas, M
(1999). Nitric oxide release in penile corpora cavernosa in a rat model of erection. J. Physiol.
516: 261-269
[Abstract][Full Text]
Litwin, M. S.
(1999). Urology. JAMA
281: 495-496
[Full Text]
Laumann, E. O., Paik, A., Rosen, R. C.
(1999). Sexual Dysfunction in the United States: Prevalence and Predictors. JAMA
281: 537-544
[Abstract][Full Text]
Cheitlin, M. D., Hutter, A. M. Jr, Brindis, R. G., Ganz, P., Kaul, S., Russell, R. O. Jr, Zusman, R. M., Forrester, J. S., Douglas, P. S., Faxon, D. P., Fisher, J. D., Gibbons, R. J., Halperin, J. L., Hutter, A. M. Jr, Hochman, J. S., Kaul, S., Weintraub, W. S., Winters, W. L. Jr, Wolk, M. J.
(1999). Use of Sildenafil (Viagra) in Patients With Cardiovascular Disease. Circulation
99: 168-177
[Full Text]
Cheitlin, M. D., Hutter, A. M., Brindis, R. G., Ganz, P., Kaul, S., Russell, R. O., Zusman, R. M., Forrester, J. S., Douglas, P. S., Faxon, D. P., Fisher, J. D., Gibbons, R. J., Halperin, J. L., Hutter, A. M., Hochman, J. S., Kaul, S., Weintraub, W. S., Winters, W. L., Wolk, M. J.
(1999). Use of sildenafil (Viagra) in patients with cardiovascular disease. J Am Coll Cardiol
33: 273-282
[Full Text]
Goldstein, I., Lue, T. F., Padma-Nathan, H., Rosen, R. C., Steers, W. D., Wicker, P. A., The Sildenafil Study Group,
(1998). Oral Sildenafil in the Treatment of Erectile Dysfunction. NEJM
338: 1397-1404
[Abstract][Full Text]
Nakatsuka, M., Nakatsuka, K., Osawa, Y.
(1998). Metabolism-Based Inactivation of Penile Nitric Oxide Synthase Activity by Guanabenz. Drug Metab. Dispos.
26: 497-501
[Abstract][Full Text]
Fei, L., Baron, A. D., Henry, D. P., Zipes, D. P.
(1997). Intrapericardial Delivery of L-Arginine Reduces the Increased Severity of Ventricular Arrhythmias During Sympathetic Stimulation in Dogs With Acute Coronary Occlusion : Nitric Oxide Modulates Sympathetic Effects on Ventricular Electrophysiological Properties. Circulation
96: 4044-4049
[Abstract][Full Text]
Joyner, M. J., Dietz, N. M.
(1997). Nitric oxide and vasodilation in human limbs. J. Appl. Physiol.
83: 1785-1796
[Abstract][Full Text]
Ayajiki, K., Hayashida, H., Okamura, T., Toda, N.
(1997). Pelvic nerve stimulation-induced pressor responses in corpus cavernosum of anesthetized dogs. Am. J. Physiol. Heart Circ. Physiol.
273: H2141-H2145
[Abstract][Full Text]
Thomson, H. L., Wright, K., Frenneaux, M.
(1997). Baroreflex Sensitivity in Patients With Vasovagal Syncope. Circulation
95: 395-400
[Abstract][Full Text]
Padma-Nathan, H., Hellstrom, W. J.G., Kaiser, F. E., Labasky, R. F., Lue, T. F., Nolten, W. E., Norwood, P. C., Peterson, C. A., Shabsigh, R., Tam, P. Y., Place, V. A., Gesundheit, N., Cowley, C., Nemo, K. J., Spivack, A. P., Stephens, D. E., Todd, L. K., The Medicated Urethral System for Erection (MUSE),
(1997). Treatment of Men with Erectile Dysfunction with Transurethral Alprostadil. NEJM
336: 1-7
[Abstract][Full Text]
Linet, O. I., Ogrinc, F. G., The Alprostadil Study Group,
(1996). Efficacy and Safety of Intracavernosal Alprostadil in Men with Erectile Dysfunction. NEJM
334: 873-877
[Abstract][Full Text]
DePalma, R. G.
(1996). The Role of the Vascular Surgeon in Impotence Management: Diagnostic Considerations. PERSPECT VASC SURG ENDOVASC THER
9: 44-52
Dawson, T. M., Dawson, V. L.
(1995). REVIEW {blacksquare} : Nitric Oxide: Actions and Pathological Roles. Neuroscientist
1: 7-18
[Abstract]
Stein, M., Chamberlin, J. W., Lerner, S. E., Gladshteyn, M.
(1993). Review Article: The Evaluation and Treatment of Sexual Dysfunction in the Neurologically Impaired Patient. Neurorehabil Neural Repair
7: 63-71
[Abstract]
Snyder, S.
(1992). Nitric oxide: first in a new class of neurotransmitters. Science
257: 494-496
Burnett, A., Lowenstein, C., Bredt, D., Chang, T., Snyder, S.
(1992). Nitric oxide: a physiologic mediator of penile erection. Science
257: 401-403
[Abstract]
(1992). NEW INSIGHT INTO THE CAUSE OF VASCULOGENIC IMPOTENCE. JWatch General
1992: 7-7
[Full Text]
Previous
